Clinical Trials Browser

Phase 2/3 × Lymphedema × Clear all

NCT06306274 2024-12-02

Topical Tacrolimus for Breast Cancer-related Lymphedema

Phase 2/3 Enrolling by invitation

Lymphedema

NCT02574780 2016-10-10

LTP

Phase 2/3 Completed

Lymphedema